Related Experiment Video

Updated: Aug 20, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Populations with high prevalence of antibody against hepatitis E virus in Israel

Y V Karetnyi, M O Favorov, N S Khudyakova

    Clinical and Diagnostic Virology
    |June 1, 1996
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Hepatitis E Virus Fluorescence Reduction Neutralization Test for Measuring Neutralizing Antibody Titers
    07:58

    Hepatitis E Virus Fluorescence Reduction Neutralization Test for Measuring Neutralizing Antibody Titers

    Published on: May 22, 2026

    Related Experiment Videos

    Last Updated: Aug 20, 2026

    A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
    10:28

    A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

    Published on: June 26, 2020

    Hepatitis E Virus Fluorescence Reduction Neutralization Test for Measuring Neutralizing Antibody Titers
    07:58

    Hepatitis E Virus Fluorescence Reduction Neutralization Test for Measuring Neutralizing Antibody Titers

    Published on: May 22, 2026

    Related Concept Videos

    Hepatitis01:25

    Hepatitis

    Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
    Viral Hepatitis I: Introduction01:28

    Viral Hepatitis I: Introduction

    Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...

    Articles linked to this work by shared authors, journal, and citation graph.

    Retrospective identification of congenital cytomegalovirus infection using dried blood samples - missed opportunities and lessons.

    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2022

    Influenza vaccine effectiveness against laboratory-confirmed influenza in a vaccine-mismatched influenza B-dominant season.

    Vaccine·2020

    Screening and exclusion of Zika virus infection in travellers by an NS1-based ELISA and qRT-PCR.

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2020

    Seroprevalence of hepatitis E virus in dromedary camels, Bedouins, Muslim Arabs and Jews in Israel, 2009-2017.

    Epidemiology and infection·2019

    Prevalence of anti-hepatitis B surface antibodies among children and adolescents vaccinated in infancy and effect of booster dose administered within a pilot study.

    Epidemiology and infection·2017

    West Nile virus outbreak in Israel in 2015: phylogenetic and geographic characterization in humans and mosquitoes.

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2017

    Defective adenoviruses as novel vaccines for the Flaviviridae.

    Clinical and diagnostic virology·1998

    Perspectives for a hepatitis C virus vaccine.

    Clinical and diagnostic virology·1998

    Evaluation of molecular strategies to develop a live dengue vaccine.

    Clinical and diagnostic virology·1998

    Ribozyme gene therapy for hepatitis C virus infection.

    Clinical and diagnostic virology·1998

    Repression of the PKR protein kinase by the hepatitis C virus NS5A protein: a potential mechanism of interferon resistance.

    Clinical and diagnostic virology·1998

    The conformation of hepatitis C virus NS3 proteinase with and without NS4A: a structural basis for the activation of the enzyme by its cofactor.

    Clinical and diagnostic virology·1998
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us